Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Long Term Follow-up Study in Patients With Telomere Biology Disorders With Bone Marrow Failure Who Completed Study EXG-US-01

NCT05868499 is registered in ClinicalTrials.gov with Elixirgen Therapeutics, Inc. as lead sponsor.

NCT NCT05868499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05868499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Long Term Follow-up Study in Patients With Telomere Biology Disorders With Bone Marrow Failure Who Completed Study EXG-US-01
Lead sponsor
Elixirgen Therapeutics, Inc.
Phase
Phase 1
Overall status
Enrolling by invitation
Start date
January 1, 2024
Completion date
January 30, 2027
Enrollment
12 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

telomere biology disorders with bone marrow failure